Amytrx Therapeutics

0 followers


Amytrx Therapeutics is advancing a new class of peptide therapies to overcome inflammatory diseases—with a vision of providing transformative medicines to patients.

Industries

Headquarters

Stage

Employees

Links

Org chart

Matthew A. Gonda
President, CEO & Founder

Matthew A. Gonda

Collapse
Randall B. Riggs
Chief Business Officer
Vernon L. Alvarez
SVP, Research & Development
Shima Joshi
VP, Regulatory Affairs
Randy Riggs
Chief Business Officer